pharmaphorum| News & views on pharma and biotech’s evolving future

Patients

Sponsored

Protecting continuity of care through sustainable respirator...

More attention is being paid to how care can be delivered in ways that maintain continuity for patients while also being environmentally responsible.

News

Karyopharm eyes Xpovio filing in myelofibrosis on mixed data

Despite hitting just one of two efficacy endpoints in a pivotal trial, Karyopharm thinks it still has a path to approval for Xpovio in myelofibrosis.

R&D

Redesigning obesity trials for a chronic disease era

Market Access

BIO-Europe Spring, Portugal: Propelling new wave innovation

BIO-Europe Spring arrived in Lisbon, Portugal yesterday, running from 23rd to 25th March.

News

MSD taps Quotient for IBD drug targets in $2.2bn deal

MSD is paying $20m upfront to activate an alliance with Flagship's Quotient Therapeutics to find new targets in inflammatory bowel disease.

Featured Content

Market Access

BIO-Europe Spring, Portugal: Propelling new wave innovation

BIO-Europe Spring arrived in Lisbon, Portugal yesterday, running from 23rd to 25th March.

R&D

Redesigning obesity trials for a chronic disease era

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

R&D

pharmaphorum podcast Episode 249, Michelle Werner, Alltrna

Treating genetic disease at scale with tRNA, with Michelle W...

Michelle Werner, Director of Alltrna, discusses her company’s approach of leveraging transfer RNA (tRNA) to shift the paradigm in genetic medicine.

R&D

Interview at BIO-Europe 2026 with Robert Jacks

BIO-Europe Spring 2026: In conversation with Robert Jacks

Digital

Sponsored

Expert Directed Applied Intelligence: Redefining AI in Life ...

In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.

Newsletters and Deep Dive
digital magazine

Latest News

News

Karyopharm eyes Xpovio filing in myelofibrosis on mixed data

Despite hitting just one of two efficacy endpoints in a pivotal trial, Karyopharm thinks it still has a path to approval for Xpovio in myelofibrosis.

News

MSD taps Quotient for IBD drug targets in $2.2bn deal

MSD is paying $20m upfront to activate an alliance with Flagship's Quotient Therapeutics to find new targets in inflammatory bowel disease.

News

AstraZeneca reportedly hit by serious cyberattack

A hacking group claims to have broken into AstraZeneca's IT systems and stolen confidential data, which they are now offering for sale.

News

Keytruda cleared for NHS use in early head and neck cancer

MSD's Keytruda is poised to end a 20-year drought in new advances in NHS treatment for early-stage head and neck cancer.

Views & Analysis

Market Access

BIO-Europe Spring, Portugal: Propelling new wave innovation

BIO-Europe Spring arrived in Lisbon, Portugal yesterday, running from 23rd to 25th March.

Market Access

Is AI the missing link in fixing MLR – or the reason it brea...

Somewhere in a shared drive at a mid-size pharma company, there is a folder labelled “Q3 Messaging FINAL v3 (2).” Inside it are three Word documents with tracked changes from four people, n

R&D

BIO-Europe Spring 2026: In conversation with Robert Jacks

Market Access

Reuters Antitrust Correspondent Jody Godoy interviews FTC Bureau of Competition Director Daniel Guarnera at Reuters Pharma USA in Philadelphia.

FTC leader: "We're up to the challenge" of coming merger boo...

At Reuters Pharma USA, the FTC's Daniel Guarnera warned that healthcare is a major priority and they're ready to move against anticompetitive deals.

Deep Dive

R&D

The GLP-1 Reckoning

R&D

GLP-1s: Five years that changed metabolic medicine

R&D

Redesigning obesity trials for a chronic disease era

R&D

The trust gap: GLP-1s and the new information economy of obe...

White Papers & Webinar

Sales & Marketing

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Digital

Sponsored

Expert Directed Applied Intelligence: Redefining AI in Life ...

In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.

Sales & Marketing

Lumanity white paper - person at top of mountain range

Sponsored

The strategic imperative of Integrated Evidence Generation P...

Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.

Digital

White paper from Veeva on Clinical Data Industry Research

Sponsored

Data managers and CRAs warn of rising data quality risks due...

A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.

Podcasts & Video

R&D

The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2026)

Featured Content

Editor's Picks

Latest News

Views & Analysis

Deep Dive

White Papers & Webinar

Podcasts & Video

Partner Content